Diazepam

Formulation

The table below describes the formulation of diazepam and the controls morphine sulfate and gabapentin for the experiments shown on this page.

Experiment(s) Compound Dose(s) mg/kg Correction factor Dose volume mL/kg Route Vehicle Suspension / Solution
Pharmacokinetics Diazepam 3, 10 1.00 1 PO TPS Suspension
Irwin, Rotarod Diazepam 1, 3, 10, 30 1.00 5 PO TPS Suspension
Plantar incision, Diazepam 1, 3, 10 1.00 5 PO TPS Suspension
L5/L6 SNL
Plantar incision Morphine 6 1.33 1 SC Saline Solution
L5/L6 SNL Gabapentin 60 1.00 1 PO Saline Solution

L5/L6 SNL = L5/L6 spinal nerve ligation; PO = per os; SC = subcutaneous; TPS = 5% Tween 80, 5% polyethylene glycol (PEG) 300, and 90% saline


Results

Expand and Collapse accordion content

Method: Rat Rotarod
Two graphs show the latency for male or female rats to fall off a rotarod apparatus. Responses are shown at the following time points: baseline (before treatment) and at 1, 2, 4, and 6 hours after treatment with vehicle (5% Tween 80 and 5% PEG 300 in saline, delivered PO) or diazepam (1, 3, 10, or 30 mg/kg, delivered PO). There were 10 rats per group. A significant interaction of time x treatment was found in a two-way repeated measures ANOVA for each sex. Bonferroni’s tests found a significant decrease in latency to fall relative to the vehicle group in males at 1 hour post-treatment with 30 mg/kg diazepam (p<0.01). Bonferroni’s tests found significant decreases in latency to fall relative to the vehicle group in females at 1 hour post-treatment with 10 mg/kg diazepam (p<0.05) and 30 mg/kg diazepam (p<0.0001) and at 2 hours post-treatment with 30 mg/kg diazepam (p<0.05).


This work was conducted by PsychoGenics Inc. (Paramus, NJ) in collaboration with PSPP, NINDS, NIH under contract # 75N95019D00026. Prescribing information for clinically used controls can be found at labels.fda.gov.